ArticleJACS Au2026
Water-Tolerant Iminium Reactive Species for Tyrosine-Specific Functionalization.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a novel, metal-free, and biocompatible method for tyrosine-specific functionalization using kinetically persistent iminium intermediates in aqueous media. By employing weakly coordinating anion-based ion-pair catalysts, this approach overcomes the inherent instability of iminium species in water, enabling efficient conjugation with phenolic compounds. The method showcases broad applicability, including the functionalization of pharmaceuticals, phenol-containing natural products, and tyrosine residues in biopolymers, all under mild and environmentally friendly conditions. Importantly, the approach preserves stereochemical integrity during biomolecule modifications and achieves high chemo- and regioselectivity. This work offers a versatile platform for biofunctionalization, with potential applications in drug discovery, therapeutic innovation, and biomolecular engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.